rs193922639
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BS1BS2
The NM_001943.5(DSG2):c.1174G>A(p.Val392Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,614,094 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001943.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSG2 | NM_001943.5 | c.1174G>A | p.Val392Ile | missense_variant | 9/15 | ENST00000261590.13 | NP_001934.2 | |
DSG2 | XM_047437315.1 | c.640G>A | p.Val214Ile | missense_variant | 10/16 | XP_047293271.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSG2 | ENST00000261590.13 | c.1174G>A | p.Val392Ile | missense_variant | 9/15 | 1 | NM_001943.5 | ENSP00000261590 | P1 | |
DSG2 | ENST00000683614.2 | n.1005G>A | non_coding_transcript_exon_variant | 7/7 |
Frequencies
GnomAD3 genomes AF: 0.00164 AC: 249AN: 152138Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00219 AC: 545AN: 249420Hom.: 3 AF XY: 0.00243 AC XY: 329AN XY: 135312
GnomAD4 exome AF: 0.00273 AC: 3984AN: 1461838Hom.: 13 Cov.: 31 AF XY: 0.00286 AC XY: 2077AN XY: 727224
GnomAD4 genome AF: 0.00164 AC: 249AN: 152256Hom.: 1 Cov.: 32 AF XY: 0.00156 AC XY: 116AN XY: 74442
ClinVar
Submissions by phenotype
not provided Benign:6
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 08, 2020 | This variant is associated with the following publications: (PMID: 23812740, 26899768, 25637381, 23299917, 21636032, 24070718, 17105751, 20031616, 20129281, 20829228, 21606390, 21859740, 21606396, 21723241, 23071725, 23396983, 24436435, 24055113, 26138720, 26681313, 27153395, 25985138, 28255936, 29062102, 30885746) - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | Aug 22, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | DSG2: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 28, 2023 | - - |
Likely benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
not specified Benign:5
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 03, 2015 | p.Val392Ile in exon 9 of DSG2: This variant has been reported in many individual s with diverse presentations (ARVC, LQTS1, LDAC, DCM: Syrris 2007, Bhuiyan 2009, Bauce 2010, Klauke 2010, Quarta 2011, Cox 2011, Bauce 2011, Garcia-Parva 2011, LMM unpublished data). However, this variant has also been identified in 0.7% (1 11/16510) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org;dbSNP rs193922639). In addition, valine (Val) at position 392 is poorly conserved in evolution and the variant is present in two species (including 1 mammal), suggesting that a change to this position may be t olerated. In summary, this variant is likely benign but a modifying role cannot be excluded. - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 26, 2019 | Variant summary: DSG2 c.1174G>A (p.Val392Ile) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0022 in 249420 control chromosomes in the gnomAD database, including 3 homozygotes. The observed variant frequency is approximately 200 fold of the estimated maximal expected allele frequency for a pathogenic variant in DSG2 causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is benign. Though c.1174G>A has been reported in the literature in individuals affected with ARVC/D, LQTS and DCM, including families showing incomplete co-segregation with disease, in addition, multiple co-occurrences with other pathogenic variants have been noted (PKP2 c.148_151delACAG (p.Thr50fsX61), Bauce_2010, Rigato_2013; PKP2 c.235C>T (p.Arg79X), Cox _2011), providing supporting evidence for a benign role. Publication also reported experimental evidence evaluating an impact on protein function, and demonstrated no damaging effect of this variant (Gaertner_2012, Dieding_2017). Six other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as Benign (2x), Likely benign (3x) or VUS (1x). Based on the evidence outlined above, the variant was classified as benign. - |
Arrhythmogenic right ventricular cardiomyopathy Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | research | Biesecker Lab/Clinical Genomics Section, National Institutes of Health | Jun 24, 2013 | - - |
Uncertain significance, criteria provided, single submitter | research | CSER _CC_NCGL, University of Washington | Jun 01, 2014 | Low GERP score may suggest that this variant may belong in a lower pathogenicity class - |
Cardiomyopathy Benign:2
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jul 25, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jun 11, 2018 | - - |
Arrhythmogenic right ventricular dysplasia 10 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Arrhythmogenic right ventricular dysplasia 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | Jul 25, 2019 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 08, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at